REG - Holmes Master Issuer - Publication of Suppl.Prospcts

British LandAnnouncement

15/08/2023 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230815:nRSO3960Ja&default-theme=true

RNS Number : 3960J  Holmes Master Issuer plc  15 August 2023

HOLMES MASTER ISSUER PLC

(a public company incorporated with limited liability in England and Wales
with registered number 05953811)

 

Publication of Supplemental Prospectus

 

The following prospectus supplement has been approved by the UK Financial
Conduct Authority and is available for viewing:

Supplement dated 15 August 2023 (the Supplement) to the prospectus dated 12
May 2023 relating to the Residential Mortgage-Backed Note Programme of Holmes
Master Issuer plc (the Prospectus).

The Supplement is available for viewing by clicking on or pasting the
following URL into the address bar of your browser:

https://data.fca.org.uk/artefacts/NSM/Portal/NI-000081088/NI-000081088.pdf
(https://data.fca.org.uk/artefacts/NSM/Portal/NI-000081088/NI-000081088.pdf)

 

A copy of the Supplement has been submitted to the National Storage Mechanism
and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

The Supplement will also be available for viewing at:

 

https://www.santander.co.uk/about-santander/investor-relations/holmes-master-trust
(https://www.santander.co.uk/about-santander/investor-relations/holmes-master-trust)

 

For further information, please contact:

 

Medium Term Funding

Santander UK plc

2 Triton Square

Regent's Place

London

NW1 3AN

 

Email: mtf@santander.co.uk (mailto:mtf@santander.co.uk)

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplement (and the
Prospectus to which it relates) may be addressed to and/or targeted at persons
who are residents of particular countries (as specified in the Supplement and
the Prospectus) only and is not intended for use and should not be relied upon
by any person outside these countries and/or to whom the offer contained in
the Supplement and the Prospectus is not addressed. Prior to relying on the
information contained in the Supplement and the Prospectus, you must ascertain
from the Supplement and the Prospectus whether or not you are part of the
intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above
requirement.

 

The securities described herein have not been, and will not be, registered
under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or
under any relevant securities laws of any state of the United States of
America, and may not be offered or sold in, the United States of America, or
to, or for the benefit of, U.S. persons (as defined in Regulation S of the
Securities Act) except to persons that are qualified institutional buyers
within the meaning of Rule 144A under the Securities Act, or in transactions
that occur outside the United States to persons other than U.S. persons in
accordance with Regulation S, unless the securities are registered under the
Securities Act or an exemption from the registration requirements of the
Securities Act is available.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPEAFPSFEFDEFA